# EDGAR Filing Document

**Accession Number:** 0001034670
**File Stem:** 0001193125-26-160203
**Filing Date:** 2026-4
**Character Count:** 105301
**Document Hash:** 4fa5619d9a1555a9ed6663dd1196f43c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-160203.hdr.sgml**: 20260417

**ACCESSION NUMBER**: 0001193125-26-160203

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 19

**CONFORMED PERIOD OF REPORT**: 20260417

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260417

**DATE AS OF CHANGE**: 20260417

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AUTOLIV INC
- **CENTRAL INDEX KEY:** 0001034670
- **STANDARD INDUSTRIAL CLASSIFICATION:** MOTOR VEHICLE PARTS & ACCESSORIES [3714]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 510378542
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-12933
- **FILM NUMBER:** 26869336

**BUSINESS ADDRESS:**
- **STREET 1:** 3350 AIRPORT RD
- **CITY:** OGDEN
- **STATE:** UT
- **ZIP:** 84405
- **BUSINESS PHONE:** 8016299800

**MAIL ADDRESS:**
- **STREET 1:** BOX 70381
- **STREET 2:** SE 107 24 STOCKHOLM
- **CITY:** SWEDEN
- **STATE:** V7

?xml version='1.0' encoding='ASCII'? 8-K

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549**

------

## FORM 8-K

------

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d)**

 **of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported):** April 17, 2026<br>

------

Autoliv, Inc.

**(Exact name of Registrant as Specified in Its Charter)**

------

---

| | | |
|:---|:---|:---|
| Delaware | 001-12933 | Not applicable |
| **(State or Other Jurisdiction<br>of Incorporation)** | **(Commission File Number)** | **(IRS Employer<br>Identification No.)** |
| Klarabergsviadukten 70, Section D<br>5th Floor,<br>Box 70381,  |  |  |
| Stockholm, Sweden |  | SE-107 24 |
| **(Address of Principal Executive Offices)** |  | **(Zip Code)** |

---

+46 8 587 20 600 <br> (Registrant's Telephone Number, Including Area Code)

**Not Applicable**<br>

(Former Name or Former Address, if Changed Since Last Report)

------

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **<br>Title of each class** | **Trading<br>Symbol(s)** | **<br>Name of each exchange on which registered** |
| Common Stock (par value $1.00 per share) | ALV | New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

## Item 2.02 Results of Operations and Financial Condition.
On April 17, 2026, Autoliv, Inc. (the "Company") issued a press release announcing its financial results for the first quarter of 2026. A copy of the press release is furnished as Exhibit 99.1 to this report and is incorporated herein by reference. This press release contains certain references to financial measures identified as "organic sales," "adjusted operating income," "adjusted operating margin," "adjusted other non-operating items, net," "trade working capital," "adjusted earnings per share - diluted," "net debt," "adjusted EBITDA," "free operating cash flow," "cash conversion," "leverage ratio," and "adjusted return on capital employed," "adjusted return on total equity," all of which are adjustments from comparable measures calculated and presented in accordance with U.S. generally accepted accounting principles (GAAP). These financial measures, as used herein, differ from financial measures reported under GAAP, and management believes that these financial presentations provide useful supplemental information, which is important to a proper understanding by investors of the Company's core business results. These presentations should not be viewed as a substitute for results determined in accordance with GAAP, nor are they necessarily comparable to non-GAAP financial measures presented by other companies. For an explanation of the reasons why management uses these figures, see the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the SEC on February 19, 2026, and the Press Release regarding its financial results for the first quarter of 2026. A copy of the press release is furnished as Exhibit 99.1 to this report.

## Item 7.01 Regulation FD Disclosure.
On April 17, 2026, the Company issued a press release announcing its financial results for the first quarter of 2026. A copy of the press release is furnished as Exhibit 99.1 to this report and is incorporated herein by reference.

## Item 9.01 Financial Statements and Exhibits.
(d) EXHIBITS

99.1 [<u>Press Release of Autoliv, Inc. dated April 17, 2026.</u>](alv-ex99_1.htm) <br> 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

------

**EXHIBIT INDEX**

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 99.1 | [<u>Press Release of Autoliv, Inc. dated April 17, 2026.</u>](alv-ex99_1.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
| AUTOLIV, INC | AUTOLIV, INC |
| By: | /s/ Anthony J. Nellis |
| Name: | Anthony J. Nellis |
| Title: | Executive Vice President, Legal Affairs and General Counsel |

---

Date: April 17, 2026

------

## Exhibit 99.1

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**Exhibit 99.1**

![img180290266_0.jpg](img180290266_0.jpg)

---

| | |
|:---|:---|
| **Financial Report**<br>&nbsp;&nbsp;&nbsp;&nbsp; January - March 2026<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stockholm, Sweden, April 17, 2026 <br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(NYSE: ALV and SSE: ALIV.sdb) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br>![img180290266_1.jpg](img180290266_1.jpg) |

---

------

Financial Report January - March 2026

Q1 2026: Solid operational performance and sales

---

| | |
|:---|:---|
| &nbsp;&nbsp;**Financial highlights Q1 2026**<br>**$2,753 million** net sales, **increase** of **6.8%** <br>**0.8%** organic sales growth\*<br>**8.6%** operating margin, **8.9%** adj. operating margin\*<br>**$1.88** diluted EPS, **12% decrease** | &nbsp;&nbsp;**Full year 2026 guidance**<br>**Around 0%** organic sales growth<br>**Around 3% positive** FX impact on net sales<br>**Around 10.5-11%** adjusted operating margin<br>**Around $1.2 billion** operating cash flow |

---

***All change figures in this release compare to the same period of the previous year except when stated otherwise.***

# Key business developments in the first quarter of 2026
&nbsp;&nbsp;&nbsp;&nbsp;•**Net sales increased organically\* by 0.8%**, which was 4.2pp higher than the global LVP decrease of 3.4% (S&P Global Apr 2026) driven mainly by strong progress in Asia. Regional and customer LVP mix is estimated to have impacted sales positively by about 1.5pp, while tariff compensations added around 0.5pp. Our organic sales growth\* outperformed LVP significantly in China (15pp) and Asia excl. China (6.8pp) and performed in line in EMEA and underperformed in Americas (4.5pp). Our strong performance in Asia excl. China was mainly due to India, where we outperformed by 28pp, driven by continued strong market growth in safety content per vehicle, while our China performance was mainly driven by further improved presence with Chinese OEMs.

&nbsp;&nbsp;&nbsp;&nbsp;•**Profitability was strong.** Supported by successful execution of cost reductions and positive FX effects, gross profit increased by 10%. Operating income decreased by 6.7% and adjusted operating income\* decreased by 3.9%, impacted by adverse FX translation effects and temporary lower R,D&E reimbursements as well as that Q1 2025 was positively impacted by one-time effects. Operating margin was 8.6% and adjusted operating margin\* was 8.9%. ROCE was 22.2% and adjusted ROCE\* was 22.9%.

&nbsp;&nbsp;&nbsp;&nbsp;•**Operating cash flow** was negative $76 million, mainly due to an increase in working capital due to strong sales in March, temporary effects expected to reverse later in the year and the high level of accounts payable at the end of 2025. Free operating cash flow\* thereby decreased to negative $159 million. The leverage ratio\* was unchanged compared to a year ago at 1.3x, below our target limit of 1.5x. In the quarter, a dividend of $0.87 per share was paid.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***\*For Non-GAAP measures see enclosed reconciliation tables.***<br>

 **Key Figures**

---

| | | | |
|:---|:---|:---|:---|
| **(Dollars in millions, except per share data)** | **Q1 2026** | **Q1 2025** | **Change** |
| Net sales | $2753 | $2578 | 6.8% |
| Operating income | 237 | 254 | (6.7)% |
| Adjusted operating income<sup>1)</sup> | 245 | 255 | (3.9)% |
| Operating margin | 8.6% | 9.9% | (1.2)pp |
| Adjusted operating margin<sup>1)</sup> | 8.9% | 9.9% | (1.0)pp |
| Earnings per share - diluted | 1.88 | 2.14 | (12)% |
| Adjusted earnings per share - diluted<sup>1)</sup> | 2.05 | 2.15 | (4.7)% |
| Operating cash flow | (76) | 77 | n/a |
| Return on capital employed<sup>2)</sup> | 22.2% | 25.6% | (3.3)pp |
| Adjusted return on capital employed<sup>1,2)</sup> | 22.9% | 25.6% | (2.7)pp |
| Dividends paid | (65) | (54) | 20% |
| Share repurchases | - | (50) | (100)% |
| <sup>1)</sup> Excluding effects from capacity alignments and antitrust related matters. Non-GAAP measure, see reconciliation table.<br><sup>2)</sup> Annualized operating income and income from equity method investments, relative to average capital employed. | <sup>1)</sup> Excluding effects from capacity alignments and antitrust related matters. Non-GAAP measure, see reconciliation table.<br><sup>2)</sup> Annualized operating income and income from equity method investments, relative to average capital employed. | <sup>1)</sup> Excluding effects from capacity alignments and antitrust related matters. Non-GAAP measure, see reconciliation table.<br><sup>2)</sup> Annualized operating income and income from equity method investments, relative to average capital employed. | <sup>1)</sup> Excluding effects from capacity alignments and antitrust related matters. Non-GAAP measure, see reconciliation table.<br><sup>2)</sup> Annualized operating income and income from equity method investments, relative to average capital employed. |

---

---

| | | |
|:---|:---|:---|
| **Comments from Mikael Bratt, President & CEO** | **Comments from Mikael Bratt, President & CEO** |  |
| ![img180290266_2.jpg](img180290266_2.jpg) | The first quarter turned out better than we had anticipated, with strong sales in March. Our operational performance exceeded our expectations, with solid productivity improvements, partly supported by reduced call-off volatility. Underlying profitability improved, with gross profit increasing by 10%, although adjusted operating income was slightly lower due to temporary lower  | I am pleased that we in the quarter introduced our first airbag for motorcycles, as well as our first wearable airbag solution for motorcycle riders, building on our long term strategy of growing business outside our traditional core business.<br>The quarter was characterized by ongoing and new geopolitical challenges. At this point, it is difficult to fully assess the likely impacts, as the situation remains fluid. We continue to carefully monitor the developments while preparing for various scenarios, including different mitigation strategies. <br>The business environment is uncertain but our current best estimate for the remainder of the year is a re-iteration of our full year 2026 guidance of about unchanged organic sales and an adjusted operating margin of around 10.5-11%. This is based on the assumption that LVP will decline by around 1%.<br>Our balance sheet is healthy, with debt leverage of 1.3x, well below our target limit of 1.5x. Based on our guidance for sales and adjusted operating margin, we continue to expect strong cash flow for the year, which supports our ambitions to provide attractive shareholder returns, including to repurchase shares of $300-500 million in 2026. |
| R,D&E reimbursements and the one-time income in Q1 last year.<br>Our positive trend in Asia continued, with strong growth in India, South Korea and China. In China, we continued to grow faster than LVP, especially with the Chinese OEMs, outperforming by 40pp. In India, we grew sales organically by 38%, reflecting mainly the trend of increased safety content in vehicles in India, as well as the continued high level of LVP growth. We continue to expand our production capabilities in India, investing in additional inflator production capacity for future growth. | R,D&E reimbursements and the one-time income in Q1 last year.<br>Our positive trend in Asia continued, with strong growth in India, South Korea and China. In China, we continued to grow faster than LVP, especially with the Chinese OEMs, outperforming by 40pp. In India, we grew sales organically by 38%, reflecting mainly the trend of increased safety content in vehicles in India, as well as the continued high level of LVP growth. We continue to expand our production capabilities in India, investing in additional inflator production capacity for future growth. | I am pleased that we in the quarter introduced our first airbag for motorcycles, as well as our first wearable airbag solution for motorcycle riders, building on our long term strategy of growing business outside our traditional core business.<br>The quarter was characterized by ongoing and new geopolitical challenges. At this point, it is difficult to fully assess the likely impacts, as the situation remains fluid. We continue to carefully monitor the developments while preparing for various scenarios, including different mitigation strategies. <br>The business environment is uncertain but our current best estimate for the remainder of the year is a re-iteration of our full year 2026 guidance of about unchanged organic sales and an adjusted operating margin of around 10.5-11%. This is based on the assumption that LVP will decline by around 1%.<br>Our balance sheet is healthy, with debt leverage of 1.3x, well below our target limit of 1.5x. Based on our guidance for sales and adjusted operating margin, we continue to expect strong cash flow for the year, which supports our ambitions to provide attractive shareholder returns, including to repurchase shares of $300-500 million in 2026. |

---

------

Financial Report January - March 2026

Full year 2026 guidance

In addition to the assumptions below and in our business and market update below, our full year 2026 guidance is based on our customer call-offs and the achievement of our targeted cost compensation adjustments with our customers, including no material changes to tariffs or trade restrictions, as compared to what is in effect as of April 10, 2026, as well as no significant changes in the macro-economic environment, changes to customer call-off volatility or significant supply chain disruptions.

---

| | |
|:---|:---|
| Full year 2026 Guidance |  |
| Organic sales growth | Around 0% |
| Adjusted operating margin<sup>1)</sup> | Around 10.5-11% |
| Operating cash flow<sup>2)</sup> | Around $1.2 billion |
| Capex, net, % of sales | Less than 5% |
| <sup>1)</sup> Excluding effects from capacity alignments, antitrust related matters and other discrete items. <sup>2)</sup> Excluding unusual items. | <sup>1)</sup> Excluding effects from capacity alignments, antitrust related matters and other discrete items. <sup>2)</sup> Excluding unusual items. |

---

---

| | |
|:---|:---|
| Full year 2026 Assumptions |  |
| LVP growth | Around 1% negative |
| FX impact on net sales | Around 3% positive |
| Tax rate<sup>3)</sup> | Around 28% |
| <sup>3)</sup> Excluding unusual tax items. |  |

---

The forward-looking Non-GAAP financial measures above are provided on a Non-GAAP basis. Autoliv has not provided a GAAP reconciliation of these measures because items that impact these measures, such as costs and gains related to capacity alignments and antitrust matters, cannot be reasonably predicted or determined. As a result, such reconciliation is not available without unreasonable efforts and Autoliv is unable to determine the probable significance of the unavailable information.

Conference call and webcast

The earnings conference call will be held at 2:00 p.m. CET today, April 17, 2026. Information regarding how to participate is available on www.autoliv.com. The presentation slides for the conference call will be available on our website shortly after the publication of this financial report.

------

Financial Report January - March 2026

Business and market condition update

Supply Chain

Call-off volatility improved somewhat compared to both Q4 2025 and Q1 2025, although it still remains higher than pre-pandemic levels. Low customer demand visibility and changes to customer call-offs with short notice continued to have some negative impact on our production efficiency and profitability. We expect call-off volatility for the full year 2026 on average to be slightly improved compared to 2025 but still remain higher than pre-pandemic levels. However, the continued significant uncertainty in the geopolitical environment and future changes in tariffs and trade restrictions may lead to more negative call-off volatility.

Raw material inflation, geopolitical risks and tariffs

Raw material price changes had only a small negative impact on our profitability in the first quarter, with a gross impact of around $5 million. For the full year 2026, our current assessment is for around $90 million gross impact from higher raw material prices. We expect to be able to mitigate a majority of this headwind, mainly through internal cost reductions, material mix improvements and commercial negotiations with customers and suppliers. Given the continued uncertainty in the geopolitical environment, the effects of tariffs and trade restrictions may lead to a more adverse inflation environment. We continue to execute on productivity and cost reduction initiatives to offset these cost pressures.

The effects of the new tariffs imposed in 2025 impacted our profitability in negatively in the first quarter of 2026. Although we achieved customer compensations for more than 70% of tariff costs, the net effect on operating margin was around 40bps negative, including the dilution effect. While it is our ambition and expectation to continue passing tariff costs on to our customers, there is significant uncertainty as future recovery levels may vary. For the full year 2026, we estimate the tariff-related dilution on operating margin to be similar to the around 20 bps that it was for full year 2025.

We currently do not expect any material impact from the U.S. Supreme Court's ruling that the International Emergency Economic Powers Act did not authorize the imposition of the tariffs in 2025, as our gross exposure is limited to around $25 million and the net exposure is well below $10 million.

Ongoing geopolitical developments, including the hostilities in and around the Persian Gulf, introduce additional uncertainty into the global economic environment. These conditions may affect supply chains, commodity prices, customer demand, and broader market stability. As a result, our current financial guidance reflects the best information available today but may be subject to change should these geopolitical dynamics materially impact our operations or the markets in which we operate.

We continue to closely monitor both geopolitical developments and the tariff policy environment in order to be agile to adjust our commercial and operational responses to any such developments.

This report includes content supplied by S&P Global; Copyright© Light Vehicle Production Forecast, January and April 2026. All rights reserved.

------

Financial Report January - March 2026

Key Performance Trends

---

| | |
|:---|:---|
| Sales Development by region | Operating and adjusted\* operating income and margins |
| ![img180290266_3.jpg](img180290266_3.jpg) | <br>![img180290266_4.jpg](img180290266_4.jpg) |

---

---

| | |
|:---|:---|
| Operating cash flow and capex, net  | Shareholder returns |
| ![img180290266_5.jpg](img180290266_5.jpg) | ![img180290266_6.jpg](img180290266_6.jpg) |

---

---

| | |
|:---|:---|
| Return on Capital Employed | Cash Conversion\* |
| ![img180290266_7.jpg](img180290266_7.jpg) | ![img180290266_8.jpg](img180290266_8.jpg) |

---

## Key definitions ------------------------------------------------------------------------------------------------------------

---

| | |
|:---|:---|
| Adj. operating income and margin\*: Operating income adjusted for capacity alignments, antitrust related matters and for FY 2023 the Andrews litigation settlement. Capacity alignments include non-recurring costs related to our structural efficiency and business cycle management programs.Capex, net: Capital Expenditure, net, defined as Expenditures for Property, Plant and Equipment less Proceeds from sale of Property, Plant and Equipment. | Cash conversion\*: Free operating cash flow\* in relation to net income. Free operating cash flow defined as operating cash flow less capital expenditure, net. |

---

------

Financial Report January - March 2026

# Consolidated sales development

# First quarter 2026

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Consolidated sales** | **First quarter** | **First quarter** | **Reported change** | **Currency** | **Organic** |
| **(Dollars in millions)** | **2026** | **2025** | **(U.S. GAAP)** | **effects**<sup>1)</sup> | **change\*** |
| Airbags, Steering Wheels and Other<sup>2)</sup> | $1863 | $1752 | 6.3% | 5.6% | 0.7% |
| Seatbelt Products and Other<sup>2)</sup> | 890 | 826 | 7.8% | 6.7% | 1.1% |
| **Total** | **$2753** | **$2578** | **6.8%** | **6.0%** | **0.8%** |
| Americas | $863 | $851 | 1.3% | 6.5% | (5.2)% |
| EMEA | 835 | 764 | 9.3% | 11.1% | (1.8)% |
| Asia excl. China | 563 | 515 | 9.3% | (1.8)% | 11% |
| China | 492 | 447 | 10% | 5.1% | 4.9% |
| **Total** | **$2753** | **$2578** | **6.8%** | **6.0%** | **0.8%** |
| <sup>1)</sup> Effects from currency translations. <sup>2)</sup> Including Corporate sales. | <sup>1)</sup> Effects from currency translations. <sup>2)</sup> Including Corporate sales. | <sup>1)</sup> Effects from currency translations. <sup>2)</sup> Including Corporate sales. | <sup>1)</sup> Effects from currency translations. <sup>2)</sup> Including Corporate sales. | <sup>1)</sup> Effects from currency translations. <sup>2)</sup> Including Corporate sales. | <sup>1)</sup> Effects from currency translations. <sup>2)</sup> Including Corporate sales. |

---

---

| | |
|:---|:---|
| Sales by product – Airbags, Steering Wheels and Other<br>Sales for Airbags, Steering Wheels and Other grew organically\* by 0.7% in the quarter. The largest contributors to the increase were center airbags, driver airbags and side airbags, partly offset by declines for passenger airbags and inflatable curtains.  | Sales by product – Seatbelt Products and Other<br>Sales for Seatbelt Products and Other grew organically\* by 1.1% in the quarter. Sales increased organically in Asia excluding China, EMEA and China while sales declined in Americas. |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp; <br>Sales by region<br>Our global organic sales\* increased by 0.8% compared to the global LVP decrease of 3.4% (according to S&P Global, April 2026). The relative performance was positively impacted by product launches but also by positive effects from the regional and model LVP mix development, which we estimate contributed to about 1.5pp outperformance and by tariff compensations of around 0.5pp. Our organic sales growth\* outperformed LVP growth by 15pp in China and by 6.8pp in Asia excluding China. We performed in line with LVP in EMEA and underperformed by 4.5pp in Americas, impacted mainly by negative mix due to a high LVP growth in low content South America and a lower content on some replacement models. | <br>LVP in China declined substantially with Global OEMs declining by 8.5% and Chinese OEMs declining by 11%. Autoliv's sales to domestic OEMs increased by around 30% while our sales to global OEMs decreased by around 10%. We expect continued strong sales growth in China in 2026, driven mainly by our performance with domestic OEMs. Our strong sales growth in Asia excluding China was mainly due to 38% organic sales growth in India, reflecting LVP growth but mainly the trend of increased safety content in vehicles in India. |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Q1 2026 organic growth\*** | **Americas** | **EMEA** | **Asia excl. China** | **China** | **Global** |
| **Autoliv** | **(5.2)%** | **(1.8)%** | **11.1%** | **4.9%** | **0.8%** |
| Main growth drivers | Subaru, Stellantis | Renault, Volvo | Suzuki, Tata | Chery, EV COEM | Suzuki, Chery |
| Main decline drivers | Ford, GM | VW, Hyundai | Toyota, Subaru | VW, Honda | Ford, VW |

---

Light vehicle production development

*Change compared to the same period last year according to S&P Global*

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Q1 2026** | **Americas** | **EMEA** | **Asia excl. China** | **China** | **Global** |
| **LVP (Apr 2026)** | **(0.6)%** | **(0.8)%** | **4.3%** | **(10.1)%** | **(3.4)%** |
| LVP (Jan 2026) | (0.7)% | (1.1)% | 1.6% | (10.4)% | (4.0)% |

---

------

Financial Report January - March 2026

Financial development

---

| | | | |
|:---|:---|:---|:---|
| **Condensed Income Statement** | **First quarter** | **First quarter** | **First quarter** |
| **(Dollars in millions, except per share data)** | **2026** | **2025** | **Change** |
| Net sales | $2753 | $2578 | 6.8% |
| Cost of sales | (2227) | (2100) | 6.0% |
| **Gross profit** | **526** | **478** | **10%** |
| S,G&A | (161) | (145) | 11% |
| R,D&E, net | (120) | (95) | 26% |
| Other income (expense), net | (9) | 15 | n/a |
| **Operating income** | **237** | **254** | **(6.7)%** |
| **Adjusted operating income**<sup>1)</sup> | **245** | **255** | **(3.9)%** |
| Financial and non-operating items, net | (35) | (22) | 61% |
| **Income before taxes** | **202** | **233** | **(13)%** |
| Income taxes | (60) | (65) | (7.2)% |
| **Net income** | **$142** | **$167** | **(15)%** |
| Earnings per share - diluted<sup>2)</sup> | $1.88 | $2.14 | (12)% |
| Adjusted earnings per share - diluted<sup>1,2)</sup> | $2.05 | $2.15 | (4.7)% |
| Gross margin | 19.1% | 18.6% | 0.6pp |
| S,G&A, in relation to sales | (5.8)% | (5.6)% | (0.2)pp |
| R,D&E, net in relation to sales | (4.3)% | (3.7)% | (0.7)pp |
| Operating margin | 8.6% | 9.9% | (1.2)pp |
| Adjusted operating margin<sup>1)</sup> | 8.9% | 9.9% | (1.0)pp |
| Tax Rate | 29.9% | 28.0% | 1.9pp |
| **Other data** |  |  |  |
| No. of shares at period-end in millions<sup>2)</sup> | 74.9 | 77.3 | (3.2)% |
| Weighted average no. of shares in millions, basic<sup>2)</sup> | 74.8 | 77.6 | (3.7)% |
| Weighted average no. of shares in millions, diluted<sup>2)</sup> | 75.1 | 77.9 | (3.6)% |
| <sup>1)</sup> Non-GAAP measure, excluding effects from capacity alignments and antitrust related matters. See reconciliation table. <sup>2)</sup> Net of treasury shares. | <sup>1)</sup> Non-GAAP measure, excluding effects from capacity alignments and antitrust related matters. See reconciliation table. <sup>2)</sup> Net of treasury shares. | <sup>1)</sup> Non-GAAP measure, excluding effects from capacity alignments and antitrust related matters. See reconciliation table. <sup>2)</sup> Net of treasury shares. | <sup>1)</sup> Non-GAAP measure, excluding effects from capacity alignments and antitrust related matters. See reconciliation table. <sup>2)</sup> Net of treasury shares. |

---

---

| | |
|:---|:---|
| First quarter 2026 development<br>**Gross profit** increased by $48 million and gross margin increased by 0.6pp compared to the prior year. The drivers behind the gross profit improvement were mainly positive FX effects, improved operational efficiency with lower costs for labor as well as positive effects from higher sales. This was partly offset by increased tariff costs, net.<br>**S,G&A** costs increased by $16 million compared to the prior year, mainly due to $10 million in negative FX translation effects and $5 million in higher costs for personnel driven by wage inflation and a non-recurring cost of $4 million. S,G&A costs in relation to sales increased from 5.6% to 5.8%.<br>**R,D&E, net,** costs increased by $25 million compared to the prior year, mainly due to $11 million in lower engineering income related to timing effects, $5 million in higher personnel costs due to wage inflation and $4 million in negative FX translation effects. R,D&E, net, in relation to sales increased from 3.7% to 4.3%.<br>**Other income (expense), net,** was negative $9 million, compared to positive $15 million in the same period last year. The positive $15 million in 2025 related mainly to recycled accumulated currency translation differences related to the divestment of our idled operations in Russia while the negative $9 million in 2026 related mainly to restructuring costs in EMEA.<br>| <br>**Operating income** decreased by $17 million compared to the prior year, due to the higher costs for R,D&E, net, Other income (expense) and S,G&A, partly offset by higher gross profit as outlined above.<br>**Adjusted operating income\*** decreased by $10 million compared to the prior year, due to the higher costs for R,D&E, net, S,G&A and Other income (expense), partly offset by higher gross profit as outlined above.<br>**Financial and non-operating items, net,** was negative $35 million compared to negative $22 million a year earlier. The cost increase comes from $12 million in higher costs for non-operating items mainly related to restructuring costs in Americas.<br>**Income before taxes** decreased by $30 million compared to the prior year, mainly due to the lower operating income and higher costs for financial and non-operating items, net. <br>**Tax rate** was 29.9% compared to 28.0% the prior year. Discrete tax items, net, had an unfavorable impact of 2.3pp in the first quarter of 2026, while discrete tax items, net were not material in the corresponding quarter last year.<br>**Earnings per share, diluted** decreased by $0.26 compared to the prior year. The main drivers were $0.16 from lower operating income, $0.12 from financial and non-operating items, $0.05 from taxes partly offset by $0.07 from lower number of outstanding shares, diluted.<br>|

---

------

Financial Report January - March 2026

Selected Cash Flow and Balance Sheet Items

---

| | | | |
|:---|:---|:---|:---|
| **Selected Cash Flow items** | **First quarter** | **First quarter** | **First quarter** |
| **(Dollars in millions)** | **2026** | **2025** | **Change** |
| Net income | $142 | $167 | (15)% |
| Depreciation and amortization | 107 | 95 | 12% |
| Other non-cash adjustments, net | 25 | (6) | n/a |
| Changes in operating working capital | (349) | (179) | 95% |
| **Operating cash flow** | **(76)** | **77** | **n/a** |
| Capital expenditure, net<sup>1)</sup> | (84) | (93) | (10)% |
| **Free operating cash flow**<sup>2)</sup> | **$(159)** | **$(16)** | **901%** |
| **Cash conversion**<sup>3)</sup> | **n/a** | **n/a** | **n/a** |
| **Shareholder returns** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;- Dividends paid | (65) | (54) | 20% |
| &nbsp;&nbsp;&nbsp;&nbsp;- Share repurchases | - | (50) | (100)% |
| &nbsp;&nbsp;Cash dividend paid per share | $(0.87) | $(0.70) | 24% |
| &nbsp;&nbsp;Capital expenditures, net in relation to sales | 3.0% | 3.6% | (0.6)pp |
| <sup>1)</sup> Defined as Expenditures for property, plant and equipment less Proceeds from sale of property, plant and equipment. <sup>2)</sup> Operating cash flow less Capital expenditure, net. Non-GAAP measure. See enclosed reconciliation table. <sup>3)</sup> Free operating cash flow relative to Net income. Non-GAAP measure. See reconciliation table. | <sup>1)</sup> Defined as Expenditures for property, plant and equipment less Proceeds from sale of property, plant and equipment. <sup>2)</sup> Operating cash flow less Capital expenditure, net. Non-GAAP measure. See enclosed reconciliation table. <sup>3)</sup> Free operating cash flow relative to Net income. Non-GAAP measure. See reconciliation table. | <sup>1)</sup> Defined as Expenditures for property, plant and equipment less Proceeds from sale of property, plant and equipment. <sup>2)</sup> Operating cash flow less Capital expenditure, net. Non-GAAP measure. See enclosed reconciliation table. <sup>3)</sup> Free operating cash flow relative to Net income. Non-GAAP measure. See reconciliation table. | <sup>1)</sup> Defined as Expenditures for property, plant and equipment less Proceeds from sale of property, plant and equipment. <sup>2)</sup> Operating cash flow less Capital expenditure, net. Non-GAAP measure. See enclosed reconciliation table. <sup>3)</sup> Free operating cash flow relative to Net income. Non-GAAP measure. See reconciliation table. |

---

---

| | | | |
|:---|:---|:---|:---|
| **Selected Balance Sheet items** | **First quarter** | **First quarter** | **First quarter** |
| **(Dollars in millions)** | **2026** | **2025** | **Change** |
| Trade working capital<sup>1)</sup> | $1506 | $1279 | 18% |
| Trade working capital in relation to sales<sup>2)</sup> | 13.7% | 12.4% | 1.3pp |
| &nbsp;&nbsp;&nbsp;&nbsp;- Receivables outstanding in relation to sales<sup>3)</sup> | 22.0% | 21.4% | 0.6pp |
| &nbsp;&nbsp;&nbsp;&nbsp;- Inventory outstanding in relation to sales<sup>4)</sup> | 8.6% | 8.9% | (0.3)pp |
| &nbsp;&nbsp;&nbsp;&nbsp;- Payables outstanding in relation to sales<sup>5)</sup> | 16.9% | 17.8% | (0.9)pp |
| Cash & cash equivalents | 342 | 322 | 6.0% |
| Gross Debt<sup>6)</sup> | 2091 | 2105 | (0.7)% |
| Net Debt<sup>7)</sup> | 1773 | 1787 | (0.8)% |
| Capital employed<sup>8)</sup> | 4417 | 4149 | 6.5% |
| Return on capital employed<sup>9)</sup> | 22.2% | 25.6% | (3.3)pp |
| Total equity | 2644 | 2361 | 12% |
| Return on total equity<sup>10)</sup> | 21.7% | 28.8% | (7.1)pp |
| Leverage ratio<sup>11)</sup> | 1.3 | 1.3 | (0.1) |
| <sup>1)</sup> Outstanding receivables and outstanding inventory less outstanding payables. Non-GAAP measure, see reconciliation table. <sup>2)</sup> Outstanding receivables and outstanding inventory less outstanding payables relative to annualized quarterly sales. Non-GAAP measure, see reconciliation table. Annualized quarterly sales is calculated as the quarterly sales amount multiplied by four. <sup>3)</sup> Outstanding receivables relative to annualized quarterly sales. <sup>4)</sup> Outstanding inventory relative to annualized quarterly sales. <sup>5)</sup> Outstanding payables relative to annualized quarterly sales. <sup>6)</sup> Short- and long-term interest-bearing debt. <sup>7)</sup> Short- and long-term debt less cash and cash equivalents and debt-related derivatives. Non-GAAP measure. See reconciliation table. <sup>8)</sup> Total equity and net debt. <sup>9)</sup> Annualized operating income and income from equity method investments, relative to average capital employed. See definitions of "Annualized operating income" in footnote to the reconciliation tables below. <sup>10)</sup> Annualized net income relative to average total equity. See definitions of "Annualized net income" in footnote to the reconciliation tables below. <sup>11)</sup> Net debt adjusted for pension liabilities in relation to EBITDA. Non-GAAP measure. See reconciliation table. | <sup>1)</sup> Outstanding receivables and outstanding inventory less outstanding payables. Non-GAAP measure, see reconciliation table. <sup>2)</sup> Outstanding receivables and outstanding inventory less outstanding payables relative to annualized quarterly sales. Non-GAAP measure, see reconciliation table. Annualized quarterly sales is calculated as the quarterly sales amount multiplied by four. <sup>3)</sup> Outstanding receivables relative to annualized quarterly sales. <sup>4)</sup> Outstanding inventory relative to annualized quarterly sales. <sup>5)</sup> Outstanding payables relative to annualized quarterly sales. <sup>6)</sup> Short- and long-term interest-bearing debt. <sup>7)</sup> Short- and long-term debt less cash and cash equivalents and debt-related derivatives. Non-GAAP measure. See reconciliation table. <sup>8)</sup> Total equity and net debt. <sup>9)</sup> Annualized operating income and income from equity method investments, relative to average capital employed. See definitions of "Annualized operating income" in footnote to the reconciliation tables below. <sup>10)</sup> Annualized net income relative to average total equity. See definitions of "Annualized net income" in footnote to the reconciliation tables below. <sup>11)</sup> Net debt adjusted for pension liabilities in relation to EBITDA. Non-GAAP measure. See reconciliation table. | <sup>1)</sup> Outstanding receivables and outstanding inventory less outstanding payables. Non-GAAP measure, see reconciliation table. <sup>2)</sup> Outstanding receivables and outstanding inventory less outstanding payables relative to annualized quarterly sales. Non-GAAP measure, see reconciliation table. Annualized quarterly sales is calculated as the quarterly sales amount multiplied by four. <sup>3)</sup> Outstanding receivables relative to annualized quarterly sales. <sup>4)</sup> Outstanding inventory relative to annualized quarterly sales. <sup>5)</sup> Outstanding payables relative to annualized quarterly sales. <sup>6)</sup> Short- and long-term interest-bearing debt. <sup>7)</sup> Short- and long-term debt less cash and cash equivalents and debt-related derivatives. Non-GAAP measure. See reconciliation table. <sup>8)</sup> Total equity and net debt. <sup>9)</sup> Annualized operating income and income from equity method investments, relative to average capital employed. See definitions of "Annualized operating income" in footnote to the reconciliation tables below. <sup>10)</sup> Annualized net income relative to average total equity. See definitions of "Annualized net income" in footnote to the reconciliation tables below. <sup>11)</sup> Net debt adjusted for pension liabilities in relation to EBITDA. Non-GAAP measure. See reconciliation table. | <sup>1)</sup> Outstanding receivables and outstanding inventory less outstanding payables. Non-GAAP measure, see reconciliation table. <sup>2)</sup> Outstanding receivables and outstanding inventory less outstanding payables relative to annualized quarterly sales. Non-GAAP measure, see reconciliation table. Annualized quarterly sales is calculated as the quarterly sales amount multiplied by four. <sup>3)</sup> Outstanding receivables relative to annualized quarterly sales. <sup>4)</sup> Outstanding inventory relative to annualized quarterly sales. <sup>5)</sup> Outstanding payables relative to annualized quarterly sales. <sup>6)</sup> Short- and long-term interest-bearing debt. <sup>7)</sup> Short- and long-term debt less cash and cash equivalents and debt-related derivatives. Non-GAAP measure. See reconciliation table. <sup>8)</sup> Total equity and net debt. <sup>9)</sup> Annualized operating income and income from equity method investments, relative to average capital employed. See definitions of "Annualized operating income" in footnote to the reconciliation tables below. <sup>10)</sup> Annualized net income relative to average total equity. See definitions of "Annualized net income" in footnote to the reconciliation tables below. <sup>11)</sup> Net debt adjusted for pension liabilities in relation to EBITDA. Non-GAAP measure. See reconciliation table. |

---

---

| | |
|:---|:---|
| First quarter 2026 development<br>**Changes in operating working capital** impacted operating cash flow by $349 million negative compared to an impact of $179 million negative in the prior year. The $349 million increase in operating working capital mainly comes from $175 million increase in receivables and $134 million decrease in accounts payables. The increase in operating working capital is mainly related to high level of sales in March 2026, other temporary effects that are expected to reverse later in the year and the high level of accounts payable at the end of December 2025.<br>**Operating cash flow** decreased by $153 million to $(76) million compared to the prior year, mainly because of the increase in operating working capital outlined above and a lower net income, partly offset by higher depreciation and other non-cash adjustments. | <br>**Capital expenditure, net,** decreased by $10 million compared to the prior year. The level of capital expenditure, net, in relation to sales declined to 3.0% versus 3.6% a year earlier. The lower level of capital expenditure, net is mainly related to the lower activity level of footprint optimization and less capacity expansion.<br>**Free operating cash flow\*** was negative $159 million compared to negative $16 million in the prior year. The decrease was due to the lower operating cash flow partly offset by the lower capital expenditure, net, as outlined above.<br>**Cash conversion\*** defined as free operating cash flow\* in relation to net income, was n/a in the quarter compared to n/a a year earlier as free operating cash flow was negative both quarters. |

---

------

Financial Report January - March 2026

---

| | |
|:---|:---|
| **Trade working capital\*** in relation to sales increased from 12.4% to 13.7%. This was mainly due to that accounts receivables in relation to sales increased from 21.4% to 22.0% due to high sales in March 2026 and other temporary effects that are expected to reverse later in the year. The increase of trade working capital in relation to sales was also due to that accounts payables decreased from 17.8% of sales to 16.9% due to geographic sales mix changes and timing effects.<br>**Net debt\*** was $1,773 million as of March 31, 2026, which was $14 million lower than a year earlier.<br>| **Total equity** as of March 31, 2026, increased by $283 million compared to March 31, 2025. This was mainly due to net income of $710 million and $103 million in positive currency translation effects, partly offset by $304 million in share repurchases, including taxes, and $249 million in dividend payments.<br>**Leverage ratio\*:** On March 31, 2026, the Company had a leverage ratio of 1.3x compared to 1.3x on March 31, 2025, as the 12 months trailing adjusted EBITDA\* increased by $74 million while net debt\* per the policy was unchanged. Our target is to have a leverage ratio not higher than 1.5x. |

---

Headcount

---

| | | | |
|:---|:---|:---|:---|
|  | **Mar 31** | **Dec 31** | **Mar 31** |
|  | **2026** | **2025** | **2025** |
| Total headcount | 64100 | 64300 | 65900 |
| Whereof: Direct headcount in manufacturing | 46700 | 47300 | 48800 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Indirect headcount | 17400 | 17000 | 17100 |
| Temporary personnel | 10% | 10% | 10% |

---

---

| | |
|:---|:---|
| As of March 31, 2026, total headcount (Full Time Equivalent) decreased by around 1,900, or 2.9%, compared to a year earlier. The indirect workforce increased by around 300, or 1.5%, mainly reflecting a change in headcount reporting classification, moving around 300 people from direct to indirect. The direct workforce decreased by approximately 2,100, or 4.4%. The decrease was supported by an improvement in customer call-off accuracy which enabled us to accelerate operating efficiency improvements and also reflecting the reclassification mentioned above. | Compared to December 31, 2025, total headcount (Full Time Equivalent) decreased by around 200, or 0.4%. Indirect headcount increased by around 300, while direct headcount decreased by approximately 600 impacted by the reclassification mentioned above.<br>|

---

------

Financial Report January - March 2026

Other Items

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;•On February 19, 2026, Autoliv announced that Mr. Martin Lundstedt, a current member of the Board of Directors, has elected not to stand for re-election. Mr. Lundstedt's service as a director will end at the 2026 Annual Stockholders Meeting. <br>•On March 6, 2026, Autoliv announced that its Board of Directors appointed Monika Grama as the new Chief Financial Officer and Executive Vice President, Finance, of the Company. Ms. Grama succeeded Fredrik Westin as of April 1, 2026. Ms. Grama has served as the Vice President, Finance of the Autoliv Europe Middle East and Africa (EMEA) division since 2020. Monika Grama joined Autoliv in 2009 and, prior to her current role, she served as Finance Manager and Managing Director of Autoliv Romania, one of Autoliv's largest production hubs globally. Ms. Grama has played a vital role in contributing to the development of the Autoliv EMEA division during a challenging period for the automotive industry.<br>•On March 6, 2026, Autoliv announced the renewal for one year of its €3 billion guaranteed euro medium term note program, originally established on April 11, 2019. | &nbsp;&nbsp;&nbsp;&nbsp;•On March 12, 2026, Autoliv announced it has together with Yamaha Motor Co. co-developed an innovative airbag system for the new Tricity commuter scooter. This is a significant step toward making advanced safety solutions accessible to a wider range of riders, moving beyond their previous availability solely on high-end motorcycles. The collaboration reflects Autoliv's continued expansion beyond its core business and supports the company's long-term strategic direction.<br>•On March 24, 2026, Autoliv announced it has developed its first complete wearable protection for motorcycle riders: a vest with an integrated airbag system designed to reduce critical injury risks in the event of a crash. This system is being launched in collaboration with RS Taichi, a leading manufacturer of motorcycle riding gear, who will bring it to market. This initiative complements Autoliv's motorcycle and bike offer and supports its long-term strategy to explore opportunities beyond its core business of airbags, seatbelts and steering wheels for light vehicles.<br>•The Board has set Thursday, May 7, 2026 as the date for the 2026 Annual Stockholders Meeting. The Board has decided that the meeting will be in-person only. |

---

---

| | |
|:---|:---|
| Next Report<br>Autoliv intends to publish the quarterly earnings report for the second quarter of 2026 on Friday, July 17, 2026. | Footnotes<br>\*Non-GAAP measures, see enclosed reconciliation tables. |
| Inquiries: Investors and Analysts<br>Anders Trapp<br>Vice President Investor Relations<br>Tel +46 (0)709 578 171<br>Henrik Kaar<br>Director Investor Relations<br>Tel +46 (0)709 578 114<br>Inquiries: Media<br>Gabriella Etemad<br>Senior Vice President Communications<br>Tel +46 (0)70 612 6424<br>Autoliv, Inc. is obliged to make this information public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the VP of Investor Relations set out above, at 12.00 CET on April 17, 2026. | Definitions and SEC Filings<br>Please refer to www.autoliv.com or to our Annual Report for definitions of terms used in this report. Autoliv's annual report to stockholders, annual report on Form 10-K, quarterly reports on Form 10-Q, proxy statements, management certifications, press releases, current reports on Form 8-K and other documents filed with the SEC can be obtained free of charge from Autoliv at the Company's address. These documents are also available at the SEC's website www.sec.gov and at Autoliv's corporate website www.autoliv.com.<br>This report includes content supplied by S&P Global; Copyright© Light Vehicle Production Forecast, January and April 2026. All rights reserved. S&P Global is a global supplier of independent industry information. The permission to use S&P Global copyrighted reports, data and information does not constitute an endorsement or approval by S&P Global of the manner, format, context, content, conclusion, opinion or viewpoint in which S&P Global reports, data and information or its derivations are used or referenced herein. |

---

------

Financial Report January - March 2026

"Safe Harbor Statement"

---

| | |
|:---|:---|
| This report contains statements that are not historical facts but rather forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include those that address activities, events or developments that Autoliv, Inc. or its management believes or anticipates may occur in the future. All forward-looking statements are based upon our current expectations, various assumptions and/or data available from third parties. Our expectations and assumptions are expressed in good faith and we believe there is a reasonable basis for them. However, there can be no assurance that such forward-looking statements will materialize or prove to be correct as forward-looking statements are inherently subject to known and unknown risks, uncertainties and other factors which may cause actual future results, performance or achievements to differ materially from the future results, performance or achievements expressed in or implied by such forward-looking statements. In some cases, you can identify these statements by forward-looking words such as "estimates", "expects", "anticipates", "projects", "plans", "intends", "believes", "may", "likely", "might", "would", "should", "could", or the negative of these terms and other comparable terminology, although not all forward-looking statements contain such words. Because these forward-looking statements involve risks and uncertainties, the outcome could differ materially from those set out in the forward-looking statements for a variety of reasons, including without limitation: general global and regional economic conditions, including the impact of inflation; changes in light vehicle production; fluctuation in vehicle production schedules for which the Company is a supplier; global supply chain disruptions, including port, transportation, and distribution delays or interruptions; supply chain disruptions, and component shortages specific to the automotive industry or the Company; potential changes to beneficial free trade agreements and regulations, such as the United States-Mexico-Canada Agreement; changes in geopolitical and other economic and political conditions or developments, including inflation, changes trade policies, tariff regimes, and other developments in and by countries in which we do business that could materially impact supply chains, margins, access to capital, or overall business performance; political stability or geopolitical conflicts; changes in general industry or market conditions, including regional economic growth or decline; changes in and the successful execution of our capacity alignment, restructuring, cost reduction, and efficiency initiatives and the market reaction thereto; loss of business from increased competition; volatility or increases in raw material, fuel, and energy costs; changes in consumer and customer preferences for end products; loss of customers or sales; legislative or regulatory changes; customer bankruptcies, consolidations or restructuring or divestiture of customer brands; unfavorable fluctuations in currencies or interest rates among the various jurisdictions in which we operate; market acceptance of our new products; costs or difficulties related to the integration of any new or acquired businesses and technologies; continued uncertainty in pricing and other negotiations with  | customers, including inflation and tariff compensations; successful integration of acquisitions and operations of joint ventures; successful implementation of strategic partnerships and collaborations; our ability to be awarded new business; product liability, warranty and recall claims and investigations and other litigation, civil judgments or financial penalties and customer reactions thereto; higher expenses for our pension and other postretirement benefits, including higher funding needs for our pension plans; work stoppages or other labor issues; possible adverse results of pending or future litigation or infringement claims, and the availability of insurance with respect to such matters; our ability to protect our intellectual property rights; negative impacts of antitrust investigations or other governmental investigations and associated litigation relating to the conduct of our business; tax assessments or results of tax audits by governmental authorities and changes in our effective tax rate; dependence on key personnel; our ability to meet our sustainability targets, goals and commitments; dependence on and relationships with customers and suppliers; the conditions necessary to hit our financial targets; and other risks and uncertainties identified under the headings "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our Annual Reports and Quarterly Reports on Forms 10-K and 10-Q and any amendments thereto. For any forward-looking statements contained in this or any other document, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we assume no obligation to update publicly or revise any forward-looking statements in light of new information or future events, except as required by law. |

---

------

Financial Report January - March 2026

Consolidated Statements of Income

---

| | | | |
|:---|:---|:---|:---|
|  | **First quarter** | **First quarter** | **Full Year** |
| **(Dollars in millions, except per share data, unaudited)** | **2026** | **2025** | **2025** |
| Airbags, Steering Wheels and Other<sup>1)</sup> | $1863 | $1752 | $7302 |
| Seatbelt products and Other<sup>1)</sup> | 890 | 826 | 3513 |
| **Total net sales** | **2753** | **2578** | **10815** |
| Cost of sales | (2227) | (2100) | (8741) |
| **Gross profit** | **526** | **478** | **2074** |
| Selling, general & administrative expenses | (161) | (145) | (571) |
| Research, development & engineering expenses, net | (120) | (95) | (413) |
| Other income (expense), net | (9) | 15 | (2) |
| **Operating income** | **237** | **254** | **1088** |
| Income from equity method investments | 1 | 1 | 6 |
| Interest income | 3 | 2 | 10 |
| Interest expense | (26) | (25) | (103) |
| Other non-operating items, net | (12) | 0 | (15) |
| **Income before income taxes** | **202** | **233** | **986** |
| Income taxes | (60) | (65) | (250) |
| **Net income** | **142** | **167** | **736** |
| Less: Net income attributable to non-controlling interest | 0 | 0 | 1 |
| **Net income attributable to controlling interest** | **$141** | **$167** | **$735** |
| **Earnings per share - diluted** | **$1.88** | **$2.14** | **$9.55** |
| <sup>1)</sup> Including Corporate sales. | <sup>1)</sup> Including Corporate sales. | <sup>1)</sup> Including Corporate sales. | <sup>1)</sup> Including Corporate sales. |

---

------

Financial Report January - March 2026

Consolidated Balance Sheets

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Mar 31** | **Dec 31** | **Sep 30** | **Jun 30** | **Mar 31** |
| **(Dollars in millions, unaudited)** | **2026** | **2025** | **2025** | **2025** | **2025** |
| *Assets* |  |  |  |  |  |
| Cash & cash equivalents | $342 | $604 | $225 | $237 | $322 |
| Receivables, net | 2422 | 2236 | 2357 | 2341 | 2205 |
| Inventories, net | 947 | 992 | 1036 | 957 | 913 |
| Prepaid expenses | 206 | 212 | 226 | 249 | 184 |
| Other current assets | 71 | 57 | 102 | 146 | 75 |
| **Total current assets** | **3987** | **4101** | **3946** | **3929** | **3699** |
| Property, plant & equipment, net | 2356 | 2417 | 2402 | 2399 | 2286 |
| Operating leases right-of-use assets | 166 | 171 | 167 | 171 | 168 |
| Goodwill and intangible assets, net | 1392 | 1386 | 1387 | 1389 | 1380 |
| Investments and other non-current assets | 567 | 568 | 561 | 588 | 581 |
| **Total assets** | **8468** | **8644** | **8463** | **8476** | **8114** |
| *Liabilities and equity* |  |  |  |  |  |
| Short-term debt | 393 | 419 | 654 | 679 | 540 |
| Accounts payable | 1862 | 2007 | 1889 | 1945 | 1839 |
| Accrued liabilities | 1024 | 1050 | 1172 | 1138 | 1053 |
| Operating lease liabilities - current | 43 | 43 | 44 | 44 | 42 |
| Other current liabilities | 386 | 404 | 383 | 430 | 327 |
| **Total current liabilities** | **3708** | **3923** | **4141** | **4235** | **3800** |
| Long-term debt | 1699 | 1734 | 1374 | 1372 | 1565 |
| Pension liability | 176 | 169 | 167 | 167 | 163 |
| Operating lease liabilities - non-current | 117 | 122 | 118 | 121 | 120 |
| Other non-current liabilities | 125 | 113 | 105 | 102 | 103 |
| **Total non-current liabilities** | **2115** | **2138** | **1763** | **1762** | **1952** |
| Total parent shareholders' equity | 2634 | 2572 | 2549 | 2469 | 2351 |
| Non-controlling interest | 10 | 10 | 10 | 11 | 10 |
| **Total equity** | **2644** | **2582** | **2559** | **2480** | **2361** |
| **Total liabilities and equity** | **$8468** | **$8644** | **$8463** | **$8476** | **$8114** |

---

------

Financial Report January - March 2026

Consolidated Statements of Cash Flow

---

| | | | |
|:---|:---|:---|:---|
|  | **First quarter** | **First quarter** | **Full Year** |
| **(Dollars in millions, unaudited)** | **2026** | **2025** | **2025** |
| Net income | $142 | $167 | $736 |
| Depreciation and amortization | 107 | 95 | 407 |
| Gain on divestiture of property | - | (6) | (6) |
| Other non-cash adjustments, net | 25 | (1) | 32 |
| *Net change in operating working capital:* |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Receivables | (175) | (166) | (98) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other current assets | (36) | (24) | (26) |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories | 35 | 22 | (8) |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | (134) | 25 | 119 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses | (30) | (46) | (30) |
| &nbsp;&nbsp;&nbsp;&nbsp;Income taxes | (7) | 11 | 30 |
| **Net cash (used in) provided by operating activities** | **(76)** | **77** | **1157** |
| Expenditures for property, plant and equipment | (85) | (102) | (441) |
| Proceeds from sale of property, plant and equipment | 1 | 8 | 18 |
| **Net cash used in investing activities** | **(84)** | **(93)** | **(423)** |
| Net (decrease) increase in short term debt | (26) | 123 | 11 |
| Decrease in long-term debt | (2) | - | (311) |
| Increase in long-term debt | - | 39 | 521 |
| Dividends paid | (65) | (54) | (238) |
| Share repurchases | - | (50) | (351) |
| Common stock options exercised | - | 0 | 0 |
| Dividend paid to non-controlling interests | - | - | (1) |
| **Net cash (used in) provided by financing activities** | **(93)** | **57** | **(369)** |
| Effect of exchange rate changes on cash | (10) | (49) | (90) |
| **(Decrease) increase in cash and cash equivalents** | **(263)** | **(8)** | **274** |
| Cash and cash equivalents at period-start | 604 | 330 | 330 |
| **Cash and cash equivalents at period-end** | **$342** | **$322** | **$604** |

---

------

Financial Report January - March 2026

RECONCILIATION OF GAAP TO NON-GAAP MEASURES

In this report we sometimes refer to Non-GAAP measures that we and securities analysts use in measuring Autoliv's performance. We believe that these measures assist investors and management in analyzing trends in the Company's business for the reasons given below. Investors should not consider these Non-GAAP measures as substitutes, but rather as additions, to financial reporting measures prepared in accordance with GAAP. It should be noted that these measures, as defined, may not be comparable to similarly titled measures used by other companies.

Components in Sales Increase/Decrease

Since the Company historically generates approximately 75% of sales in currencies other than in the reporting currency (i.e., U.S. dollars) and currency rates have been volatile, we analyze the Company's sales trends and performance as changes in organic sales growth. This presents the increase or decrease in the overall U.S. dollar net sales on a comparable basis, allowing separate discussions of the impact of acquisitions/divestitures and exchange rates. The tables on page 5 present changes in organic sales growth as reconciled to the change in the total GAAP net sales.

Reconciliation of GAAP measure "Working Capital" to Non-GAAP Measure "Trade Working Capital"

Due to the need to optimize cash generation to create value for shareholders, management focuses on operationally derived trade working capital as defined in the table below. Trade working capital is an indicator of operational efficiency, which impacts the Company's ability to return value to shareholders either through dividends or share repurchases. We believe this is useful for readers to understand the efficiency of the Company' operational capital management. The reconciling items used to derive this measure are, by contrast, managed as part of our overall management of cash and debt, but they are not part of the responsibilities of day-to-day operations management.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Mar 31** | **Dec 31** | **Sep 30** | **Jun 30** | **Mar 31** |
| **(Dollars in millions)** | **2026** | **2025** | **2025** | **2025** | **2025** |
| Total current assets | $3987 | $4101 | $3946 | $3929 | $3699 |
| Total current liabilities | (3708) | (3923) | (4141) | (4235) | (3800) |
| **Working capital (GAAP)** | **278** | **178** | **(195)** | **(305)** | **(101)** |
| Less: Cash and cash equivalents | (342) | (604) | (225) | (237) | (322) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Prepaid expenses | (206) | (212) | (226) | (249) | (184) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other current assets | (71) | (57) | (102) | (146) | (75) |
| Less: Short-term debt | 393 | 419 | 654 | 679 | 540 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accrued expenses | 1024 | 1050 | 1172 | 1138 | 1053 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Operating lease liabilities - current | 43 | 43 | 44 | 44 | 42 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other current liabilities | 386 | 404 | 383 | 430 | 327 |
| **Trade working capital (Non-GAAP)** | **$1506** | **$1221** | **$1504** | **$1354** | **$1279** |
|  | **Mar 31** | **Dec 31** | **Sep 30** | **Jun 30** | **Mar 31** |
| **(Dollars in millions)** | **2026** | **2025** | **2025** | **2025** | **2025** |
| Receivables, net | $2422 | $2236 | $2357 | $2341 | $2205 |
| Inventories, net | 947 | 992 | 1036 | 957 | 913 |
| Accounts payable | (1862) | (2007) | (1889) | (1945) | (1839) |
| **Trade working capital (Non-GAAP)** | **$1506** | **$1221** | **$1504** | **$1354** | **$1279** |
| Quarterly sales | $2753 | $2817 | $2706 | $2714 | $2578 |
| Annualized quarterly sales<sup>1)</sup> | 11012 | 11269 | 10822 | 10857 | 10312 |
| **Trade working capital in relation to annualized quarterly sales** | **13.7%** | **10.8%** | **13.9%** | **12.5%** | **12.4%** |
| <sup>1)</sup> Calculated as the current quarterly sales multiplied by four. |  |  |  |  |  |

---

------

Financial Report January - March 2026

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Dec 31** | **Dec 31** | **Dec 31** | **Dec 31** |
| **(Dollars in millions)** | **2024** | **2023** | **2022** | **2021** |
| Total current assets | $3483 | $3974 | $3714 | $3675 |
| Total current liabilities | (3633) | (4035) | (3642) | (2821) |
| **Working capital (GAAP)** | **(150)** | **(61)** | **72** | **853** |
| Less: Cash and cash equivalents | (330) | (498) | (594) | (969) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Prepaid expenses | (167) | (173) | (160) | (164) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other current assets | (72) | (93) | (84) | (65) |
| Less: Short-term debt | 387 | 538 | 711 | 346 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Accrued expenses | 1056 | 1135 | 915 | 996 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Operating lease liabilities - current | 41 | 39 | 39 | 38 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other current liabilities | 351 | 345 | 283 | 297 |
| **Trade working capital (Non-GAAP)** | **$1115** | **$1232** | **$1183** | **$1332** |
|  | **Dec 31** | **Dec 31** | **Dec 31** | **Dec 31** |
| **(Dollars in millions)** | **2024** | **2023** | **2022** | **2021** |
| Receivables, net | $1993 | $2198 | $1907 | $1699 |
| Inventories, net | 921 | 1012 | 969 | 777 |
| Accounts payable | (1799) | (1978) | (1693) | (1144) |
| **Trade working capital (Non-GAAP)** | **$1115** | **$1232** | **$1183** | **$1332** |
| Quarterly sales | $2616 | $2751 | $2335 | $2119 |
| Annualized quarterly sales<sup>1)</sup> | 10463 | 11006 | 9340 | 8476 |
| **Trade working capital in relation to annualized quarterly sales** | **10.7%** | **11.2%** | **12.7%** | **15.7%** |
| <sup>1)</sup> Calculated as the fourth quarterly sales multiplied by four. |  |  |  |  |

---

Net Debt

Autoliv from time to time enters into "debt-related derivatives" (DRDs) as a part of its debt management and as part of efficiently managing the Company's overall cost of funds. Creditors and credit rating agencies use net debt adjusted for DRDs in their analyses of the Company's debt, therefore we provide this Non-GAAP measure. DRDs are fair value adjustments to the carrying value of the underlying debt. Also included in the DRDs is the unamortized fair value adjustment related to a discontinued fair value hedge that will be amortized over the remaining life of the debt. By adjusting for DRDs, the total financial liability of net debt is disclosed without grossing debt up with currency or interest fair values.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Mar 31** | **Dec 31** | **Sep 30** | **Jun 30** | **Mar 31** |
| **(Dollars in millions)** | **2026** | **2025** | **2025** | **2025** | **2025** |
| Short-term debt | $393 | $419 | $654 | $679 | $540 |
| Long-term debt | 1699 | 1734 | 1374 | 1372 | 1565 |
| **Total debt (GAAP)** | **2091** | **2153** | **2027** | **2051** | **2105** |
| Cash & cash equivalents | (342) | (604) | (225) | (237) | (322) |
| Debt issuance cost/Debt-related derivatives, net | 23 | 17 | (30) | (62) | 4 |
| **Net debt (Non-GAAP)** | **$1773** | **$1566** | **$1772** | **$1752** | **$1787** |
|  |  | **Dec 31** | **Dec 31** | **Dec 31** | **Dec 31** |
| **(Dollars in millions)** |  | **2024** | **2023** | **2022** | **2021** |
| Short-term debt |  | $387 | $538 | $711 | $346 |
| Long-term debt |  | 1522 | 1324 | 1054 | 1662 |
| **Total debt (GAAP)** |  | **1909** | **1862** | **1766** | **2008** |
| Cash & cash equivalents |  | (330) | (498) | (594) | (969) |
| Debt issuance cost/Debt-related derivatives, net |  | (24) | 3 | 12 | 13 |
| **Net debt (Non-GAAP)** |  | **$1554** | **$1367** | **$1184** | **$1052** |

---

Leverage ratio

The Non-GAAP measure "net debt" is also used in the Non-GAAP measure "Leverage ratio". Management uses this measure to analyze the amount of debt the Company can incur under its debt policy. Management believes that this policy also provides guidance to credit and equity investors regarding the extent to which the Company would be prepared to leverage its operations. Autoliv's policy is to maintain a leverage ratio commensurate with a strong investment grade credit rating. The Company measures its leverage ratio as net debt\* adjusted for pension liabilities in relation to adjusted EBITDA\*. The long-term target is to maintain a leverage ratio equal to or below 1.5x.

------

Financial Report January - March 2026

---

| | | | |
|:---|:---|:---|:---|
|  | **Mar 31** | **Dec 31** | **Mar 31** |
| **(Dollars in millions)** | **2026** | **2025** | **2025** |
| Net debt<sup>1)</sup> (Non-GAAP) | $1773 | $1566 | $1787 |
| Pension liabilities | 176 | 169 | 163 |
| **Net debt per the Policy (Non-GAAP)** | **$1949** | **$1736** | **$1950** |
| Net income<sup>2)</sup> | $710 | $736 | $688 |
| Income taxes<sup>2)</sup> | 246 | 250 | 246 |
| Interest expense, net<sup>2, 3)</sup> | 93 | 93 | 97 |
| Other non-operating items, net<sup>2)</sup> | 28 | 15 | 16 |
| Income from equity method investments<sup>2)</sup> | (6) | (6) | (6) |
| Depreciation and amortization of intangibles<sup>2)</sup> | 419 | 407 | 386 |
| Capacity alignments<sup>2)</sup> | 28 | 23 | 19 |
| Antitrust related items<sup>2)</sup> | 4 | 3 | 4 |
| Other items<sup>2)</sup> | - | - | (0) |
| **EBITDA per the Policy (Adjusted EBITDA) (Non-GAAP)** | **$1523** | **$1521** | **$1449** |
| **Leverage ratio (Non-GAAP)** | **1.3** | **1.1** | **1.3** |
| <sup>1)</sup> Short- and long-term debt less cash and cash equivalents and debt-related derivatives. <sup>2)</sup> Latest 12 months. <sup>3)</sup> Interest expense, including cost for extinguishment of debt, if any, less interest income. | <sup>1)</sup> Short- and long-term debt less cash and cash equivalents and debt-related derivatives. <sup>2)</sup> Latest 12 months. <sup>3)</sup> Interest expense, including cost for extinguishment of debt, if any, less interest income. | <sup>1)</sup> Short- and long-term debt less cash and cash equivalents and debt-related derivatives. <sup>2)</sup> Latest 12 months. <sup>3)</sup> Interest expense, including cost for extinguishment of debt, if any, less interest income. | <sup>1)</sup> Short- and long-term debt less cash and cash equivalents and debt-related derivatives. <sup>2)</sup> Latest 12 months. <sup>3)</sup> Interest expense, including cost for extinguishment of debt, if any, less interest income. |

---

Reconciliation of GAAP measure "Operating cash flow" to Non-GAAP measures "Free operating cash flow" and "Cash conversion"

Management uses the Non-GAAP measure "free operating cash flow" to analyze the amount of cash flow being generated by the Company's operations after capital expenditure, net. This measure indicates the Company's cash flow generation level that enables strategic value creation options such as dividends or acquisitions. For details on free operating cash flow, see the reconciliation table below. Management uses the Non-GAAP measure "cash conversion" to analyze the proportion of net income that is converted into free operating cash flow. The measure is a tool to evaluate how efficiently the Company utilizes its resources. For details on cash conversion, see the reconciliation table below.

---

| | | | |
|:---|:---|:---|:---|
|  | **First quarter** | **First quarter** | **Full Year** |
| **(Dollars in millions)** | **2026** | **2025** | **2025** |
| **Net income** | **$142** | **$167** | **$736** |
| Depreciation and amortization | 107 | 95 | 407 |
| Gain on divestiture of property | - | (6) | (6) |
| Other, net | 25 | (1) | 32 |
| Changes in operating working capital, net | (349) | (179) | (12) |
| **Operating cash flow (GAAP)** | **(76)** | **77** | **1157** |
| Expenditures for property, plant and equipment | (85) | (102) | (441) |
| Proceeds from sale of property, plant and equipment | 1 | 8 | 18 |
| **Capital expenditure, net**<sup>1)</sup> | **(84)** | **(93)** | **(423)** |
| **Free operating cash flow**<sup>2)</sup> **(Non-GAAP)** | **$(159)** | **$(16)** | **$734** |
| **Cash conversion**<sup>3)</sup> **(Non-GAAP)** | **n/a** | **n/a** | **100%** |
| <sup>1)</sup> Defined as Expenditures for property, plant and equipment less Proceeds from sale of property, plant and equipment. <sup>2)</sup> Operating cash flow less Capital expenditure, net.<br><sup>3)</sup> Free operating cash flow relative to Net income. | <sup>1)</sup> Defined as Expenditures for property, plant and equipment less Proceeds from sale of property, plant and equipment. <sup>2)</sup> Operating cash flow less Capital expenditure, net.<br><sup>3)</sup> Free operating cash flow relative to Net income. | <sup>1)</sup> Defined as Expenditures for property, plant and equipment less Proceeds from sale of property, plant and equipment. <sup>2)</sup> Operating cash flow less Capital expenditure, net.<br><sup>3)</sup> Free operating cash flow relative to Net income. | <sup>1)</sup> Defined as Expenditures for property, plant and equipment less Proceeds from sale of property, plant and equipment. <sup>2)</sup> Operating cash flow less Capital expenditure, net.<br><sup>3)</sup> Free operating cash flow relative to Net income. |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Full year** | **Full year** | **Full year** | **Full year** |
| **(Dollars in millions)** | **2024** | **2023** | **2022** | **2021** |
| **Net income** | **$648** | **$489** | **$425** | **$437** |
| Depreciation and amortization | 387 | 378 | 363 | 394 |
| Gain on divestiture of property | - | - | (80) | - |
| Other, net | (29) | (119) | (54) | (15) |
| Changes in operating working capital, net | 53 | 235 | 58 | (63) |
| **Operating cash flow (GAAP)** | **1059** | **982** | **713** | **754** |
| Expenditures for property, plant and equipment | (579) | (572) | (585) | (458) |
| Proceeds from sale of property, plant and equipment | 17 | 4 | 101 | 4 |
| **Capital expenditure, net**<sup>1)</sup> | **(563)** | **(569)** | **(485)** | **(454)** |
| **Free operating cash flow**<sup>2)</sup> **(Non-GAAP)** | **$497** | **$414** | **$228** | **$300** |
| **Cash conversion**<sup>3)</sup> **(Non-GAAP)** | **77%** | **85%** | **54%** | **69%** |
| <sup>1)</sup> Defined as Expenditures for property, plant and equipment less Proceeds from sale of property, plant and equipment. <sup>2)</sup> Operating cash flow less Capital expenditure, net.<br><sup>3)</sup> Free operating cash flow relative to net income. | <sup>1)</sup> Defined as Expenditures for property, plant and equipment less Proceeds from sale of property, plant and equipment. <sup>2)</sup> Operating cash flow less Capital expenditure, net.<br><sup>3)</sup> Free operating cash flow relative to net income. | <sup>1)</sup> Defined as Expenditures for property, plant and equipment less Proceeds from sale of property, plant and equipment. <sup>2)</sup> Operating cash flow less Capital expenditure, net.<br><sup>3)</sup> Free operating cash flow relative to net income. | <sup>1)</sup> Defined as Expenditures for property, plant and equipment less Proceeds from sale of property, plant and equipment. <sup>2)</sup> Operating cash flow less Capital expenditure, net.<br><sup>3)</sup> Free operating cash flow relative to net income. | <sup>1)</sup> Defined as Expenditures for property, plant and equipment less Proceeds from sale of property, plant and equipment. <sup>2)</sup> Operating cash flow less Capital expenditure, net.<br><sup>3)</sup> Free operating cash flow relative to net income. |

---

------

Financial Report January - March 2026

Items Affecting Comparability

We believe that comparability between periods is improved through the exclusion of certain items. To assist investors in understanding the operating performance of Autoliv's business, it is useful to consider certain GAAP measures exclusive of these items.

The following tables reconcile Income before income taxes, Net income attributable to controlling interest, Capital employed, which are inputs utilized to calculate Return On Capital Employed ("ROCE"), adjusted ROCE and Return On Total Equity ("ROE"). The Company believes this presentation may be useful to investors and industry analysts who utilize these adjusted non-U.S. GAAP measures in their ROCE and ROE calculations to exclude certain items for comparison purposes across periods. Autoliv's management uses the ROCE, adjusted ROCE and ROE measures for purposes of comparing its financial performance with the financial performance of other companies in the industry and providing useful information regarding the factors and trends affecting the Company's business.

As used by the Company, ROCE is annualized operating income and income from equity method investments, relative to average capital employed. Adjusted ROCE is annualized operating income and income from equity method investments, relative to average capital employed as adjusted to exclude certain non-recurring items. See definitions of "annualized operating income" and "average capital employed" in footnote to the tables below. The Company believes ROCE and adjusted ROCE are useful indicators of long-term performance both absolute and relative to the Company's peers as it allows for a comparison of the profitability of the Company's capital employed in its business relative to that of its peers.

ROE is the ratio of annualized income (loss) relative to average total equity for the periods presented. See definitions of "annualized income" and "average total equity" in footnote to the tables below. Adjusted ROE is annualized income (loss) relative to average total equity for the periods presented as adjusted to exclude certain non-recurring items. The Company's management believes that ROE and Adjusted ROE are useful indicators of how well management creates value for its shareholders through its operating activities and its capital management.

With respect to the Andrews litigation settlement, the Company has treated this specific settlement as a non-recurring charge because of the unique nature of the lawsuit, including the facts and legal issues involved.

Accordingly, the tables below reconcile from GAAP to the equivalent Non-GAAP measures.

Reconciliation of GAAP measure "Operating income" to Non-GAAP measure "Adjusted Operating income"

---

| | | | |
|:---|:---|:---|:---|
|  | **First quarter** | **First quarter** | **Full year** |
| **(Dollars in millions)** | **2026** | **2025** | **2025** |
| **Operating income (GAAP)** | **$237** | **$254** | **$1088** |
| *Non-GAAP adjustments:* |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Capacity alignments | 8 | 2 | 23 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Antitrust related items | 0 | (1) | 3 |
| **Total non-GAAP adjustments to operating income** | **8** | **1** | **26** |
| **Adjusted Operating income (Non-GAAP)** | **$245** | **$255** | **$1114** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **(Dollars in millions)** | **2024** | **2023** | **2022** | **2021** |
| **Operating income (GAAP)** | **$979** | **$690** | **$659** | **$675** |
| *Non-GAAP adjustments:* |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Capacity alignments<sup>1)</sup> | 19 | 218 | (61) | 8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: The Andrews litigation settlement | - | 8 | - | - |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Antitrust related items | 8 | 4 | - | - |
| **Total non-GAAP adjustments to operating income** | **27** | **230** | **(61)** | **8** |
| **Adjusted Operating income (Non-GAAP)** | **$1007** | **$920** | **$598** | **$683** |
| <sup>1)</sup> For 2022, including a gain on divestiture of property of $80 million. | <sup>1)</sup> For 2022, including a gain on divestiture of property of $80 million. | <sup>1)</sup> For 2022, including a gain on divestiture of property of $80 million. | <sup>1)</sup> For 2022, including a gain on divestiture of property of $80 million. | <sup>1)</sup> For 2022, including a gain on divestiture of property of $80 million. |

---

------

Financial Report January - March 2026

Reconciliation of GAAP measure "Operating margin" to Non-GAAP measure "Adjusted Operating margin"

---

| | | | |
|:---|:---|:---|:---|
|  | **First quarter** | **First quarter** | **Full year** |
|  | **2026** | **2025** | **2025** |
| **Operating margin (GAAP)** | **8.6%** | **9.9%** | **10.1%** |
| *Non-GAAP adjustments:* |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Capacity alignments | 0.3% | 0.1% | 0.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Antitrust related items | 0.0% | (0.0)% | 0.0% |
| **Total non-GAAP adjustments to operating margin** | **0.3%** | **0.0%** | **0.2%** |
| **Adjusted Operating margin (Non-GAAP)** | **8.9%** | **9.9%** | **10.3%** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **2024** | **2023** | **2022** | **2021** |
| **Operating margin (GAAP)** | **9.4%** | **6.6%** | **7.5%** | **8.2%** |
| *Non-GAAP adjustments:* |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Capacity alignments | 0.2% | 2.1% | (0.7)% | 0.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: The Andrews litigation settlement | - | 0.1% | - | - |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Antitrust related items | 0.1% | 0.0% | - | - |
| **Total non-GAAP adjustments to operating margin** | **0.3%** | **2.2%** | **(0.7)%** | **0.1%** |
| **Adjusted Operating margin (Non-GAAP)** | **9.7%** | **8.8%** | **6.8%** | **8.3%** |

---

Reconciliation of GAAP measure "Other non-operating items, net" to Non-GAAP measure "Adjusted Other non-operating items, net"

---

| | | |
|:---|:---|:---|
|  | **First quarter** | **First quarter** |
|  | **2026** | **2025** |
| **Other non-operating items, net (GAAP)** | **$(12)** | **$0** |
| *Non-GAAP adjustments:* |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Capacity alignments - non-operating<sup>1)</sup> | 9 | - |
| **Total non-GAAP adjustments to other non-operating items, net** | **9** | **-** |
| **Adjusted Other non-operating items, net (Non-GAAP)** | **$(3)** | **$0** |
| <sup>1)</sup> Relates to curtailment loss in connection with restructuring and capacity alignment activities. | <sup>1)</sup> Relates to curtailment loss in connection with restructuring and capacity alignment activities. | <sup>1)</sup> Relates to curtailment loss in connection with restructuring and capacity alignment activities. |

---

Reconciliation of GAAP measure "Income before income taxes" to Non-GAAP measure "Adjusted Income before income taxes"

---

| | | |
|:---|:---|:---|
|  | **First quarter** | **First quarter** |
| **(Dollars in millions)** | **2026** | **2025** |
| **Income before income taxes (GAAP)** | **$202** | **$233** |
| *Non-GAAP adjustments:* |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Capacity alignments - operating | 8 | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Capacity alignments - non-operating<sup>1)</sup> | 9 | - |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Antitrust related items | 0 | (1) |
| **Total non-GAAP adjustments to Income before income taxes** | **17** | **1** |
| **Adjusted Income before income taxes (Non-GAAP)** | **$219** | **$233** |
| <sup>1)</sup> Relates to curtailment loss in connection with restructuring and capacity alignment activities. | <sup>1)</sup> Relates to curtailment loss in connection with restructuring and capacity alignment activities. | <sup>1)</sup> Relates to curtailment loss in connection with restructuring and capacity alignment activities. |

---

Reconciliation of GAAP measure "Net income" to Non-GAAP measure "Adjusted Net income"

---

| | | |
|:---|:---|:---|
|  | **First quarter** | **First quarter** |
| **(Dollars in millions)** | **2026** | **2025** |
| **Net income (GAAP)** | **$142** | **$167** |
| *Non-GAAP adjustments:* |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Capacity alignments - operating | 8 | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Capacity alignments - non-operating<sup>1)</sup> | 9 | - |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Antitrust related items | 0 | (1) |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Tax on non-GAAP adjustments | (4) | (0) |
| **Total non-GAAP adjustments to Net income** | **12** | **1** |
| **Adjusted Net income (Non-GAAP)** | **$154** | **$168** |
| <sup>1)</sup> Relates to curtailment loss in connection with restructuring and capacity alignment activities. | <sup>1)</sup> Relates to curtailment loss in connection with restructuring and capacity alignment activities. | <sup>1)</sup> Relates to curtailment loss in connection with restructuring and capacity alignment activities. |

---

------

Financial Report January - March 2026

Reconciliation of GAAP measure "Net income attributable to controlling interest" to Non-GAAP measure "Adjusted Net income attributable to controlling interest"

---

| | | |
|:---|:---|:---|
|  | **First quarter** | **First quarter** |
| **(Dollars in millions)** | **2026** | **2025** |
| **Net income attributable to controlling interest (GAAP)** | **$141** | **$167** |
| *Non-GAAP adjustments:* |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Capacity alignments - operating | 8 | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Capacity alignments - non-operating<sup>1)</sup> | 9 | - |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Antitrust related items | 0 | (1) |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Tax on non-GAAP adjustments | (4) | (0) |
| **Total non-GAAP adjustments to Net income attributable to controlling interest** | **12** | **1** |
| **Adjusted Net income attributable to controlling interest (Non-GAAP)** | **$154** | **$167** |
| <sup>1)</sup> Relates to curtailment loss in connection with restructuring and capacity alignment activities. | <sup>1)</sup> Relates to curtailment loss in connection with restructuring and capacity alignment activities. | <sup>1)</sup> Relates to curtailment loss in connection with restructuring and capacity alignment activities. |

---

Reconciliation of GAAP measure "Earnings per share - diluted" to Non-GAAP measure "Adjusted Earnings per share - diluted"

---

| | | |
|:---|:---|:---|
|  | **First quarter** | **First quarter** |
|  | **2026** | **2025** |
| **Earnings per share - diluted (GAAP)** | **$1.88** | **$2.14** |
| *Non-GAAP adjustments:* |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Capacity alignments - operating | 0.10 | 0.02 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Capacity alignments - non-operating<sup>1)</sup> | 0.12 | - |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Antitrust related items | 0.00 | (0.02) |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Tax on non-GAAP adjustments | (0.05) | (0.00) |
| **Total non-GAAP adjustments to Earnings per share - diluted** | **0.17** | **0.01** |
| **Adjusted Earnings per share - diluted (Non-GAAP)** | **$2.05** | **$2.15** |
| Weighted average number of shares outstanding - diluted | 75.1 | 77.9 |
| <sup>1)</sup> Relates to curtailment loss in connection with restructuring and capacity alignment activities. | <sup>1)</sup> Relates to curtailment loss in connection with restructuring and capacity alignment activities. | <sup>1)</sup> Relates to curtailment loss in connection with restructuring and capacity alignment activities. |

---

Reconciliation of GAAP measure "Return on Capital Employed" to Non-GAAP measure "Adjusted Return on Capital Employed"

---

| | | |
|:---|:---|:---|
|  | **First quarter** | **First quarter** |
|  | **2026** | **2025** |
| **Return on capital employed**<sup>1)</sup> **(GAAP)** | **22.2%** | **25.6%** |
| *Non-GAAP adjustments:* |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Capacity alignments - operating | 0.7% | 0.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Antitrust related items | 0.0% | (0.1)% |
| **Total non-GAAP adjustments to Return on capital employed**<sup>1)</sup> | **0.7%** | **0.1%** |
| **Adjusted Return on capital employed**<sup>1)</sup> **(Non-GAAP)** | **22.9%** | **25.6%** |
| Annualized adjustment<sup>2)</sup> on Return on capital employed<sup>1)</sup> | $31 | $3 |
| <sup>1)</sup> Annualized operating income and income from equity method investments, relative to average capital employed. The average capital employed amount is calculated as an average of the opening balance amount and the closing balance amounts for each quarter included in the period. | <sup>1)</sup> Annualized operating income and income from equity method investments, relative to average capital employed. The average capital employed amount is calculated as an average of the opening balance amount and the closing balance amounts for each quarter included in the period. | <sup>1)</sup> Annualized operating income and income from equity method investments, relative to average capital employed. The average capital employed amount is calculated as an average of the opening balance amount and the closing balance amounts for each quarter included in the period. |
| <sup>2)</sup> The quarterly annualized adjustment to the operating income and income from equity method investments amount is calculated as the quarterly amount multiplied by four. The year-to-date annualized adjustment to the operating income and income from equity method investments amount is calculated as the year-to-date amount divided by the quarterly period number (two, three or four) multiplied by four. | <sup>2)</sup> The quarterly annualized adjustment to the operating income and income from equity method investments amount is calculated as the quarterly amount multiplied by four. The year-to-date annualized adjustment to the operating income and income from equity method investments amount is calculated as the year-to-date amount divided by the quarterly period number (two, three or four) multiplied by four. | <sup>2)</sup> The quarterly annualized adjustment to the operating income and income from equity method investments amount is calculated as the quarterly amount multiplied by four. The year-to-date annualized adjustment to the operating income and income from equity method investments amount is calculated as the year-to-date amount divided by the quarterly period number (two, three or four) multiplied by four. |

---

------

Financial Report January - March 2026

Reconciliation of GAAP measure "Return on Total Equity" to Non-GAAP measure "Adjusted Return on Total Equity"

---

| | | |
|:---|:---|:---|
|  | **First quarter** | **First quarter** |
|  | **2026** | **2025** |
| **Return on total equity**<sup>1)</sup> **(GAAP)** | **21.7%** | **28.8%** |
| *Non-GAAP adjustments:* |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Capacity alignments - operating | 1.1% | 0.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Capacity alignments - non-operating<sup>2)</sup> | 1.3% | - |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Antitrust related items | 0.0% | (0.2)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Tax on non-GAAP adjustments | (0.6)% | (0.0)% |
| **Total non-GAAP adjustments to Return on total equity**<sup>1)</sup> | **1.9%** | **0.1%** |
| **Adjusted Return on total equity**<sup>1)</sup> **(Non-GAAP)** | **23.5%** | **28.9%** |
| Annualized adjustment<sup>3)</sup> on Return on total equity<sup>1)</sup> | $50 | $2 |
| <sup>1)</sup> Annualized net income relative to average total equity. The average total equity amount is calculated as an average of the opening balance amount and the closing balance amounts for each quarter included in the period. | <sup>1)</sup> Annualized net income relative to average total equity. The average total equity amount is calculated as an average of the opening balance amount and the closing balance amounts for each quarter included in the period. | <sup>1)</sup> Annualized net income relative to average total equity. The average total equity amount is calculated as an average of the opening balance amount and the closing balance amounts for each quarter included in the period. |
| <sup>2)</sup> Relates to curtailment loss in connection with restructuring and capacity alignment activities. | <sup>2)</sup> Relates to curtailment loss in connection with restructuring and capacity alignment activities. | <sup>2)</sup> Relates to curtailment loss in connection with restructuring and capacity alignment activities. |
| <sup>3)</sup> The quarterly annualized adjustment to net income amount is calculated as the quarterly amount multiplied by four. The year-to-date annualized adjustment to the net income amount is calculated as the year-to-date amount divided by the quarterly period number (two, three or four) multiplied by four. | <sup>3)</sup> The quarterly annualized adjustment to net income amount is calculated as the quarterly amount multiplied by four. The year-to-date annualized adjustment to the net income amount is calculated as the year-to-date amount divided by the quarterly period number (two, three or four) multiplied by four. | <sup>3)</sup> The quarterly annualized adjustment to net income amount is calculated as the quarterly amount multiplied by four. The year-to-date annualized adjustment to the net income amount is calculated as the year-to-date amount divided by the quarterly period number (two, three or four) multiplied by four. |

---

------

Financial Report January - March 2026

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **(Dollars in millions, except per share data, unaudited)** | **2025** | **2024** | **2023** | **2022** | **2021** |
| **Sales and Income** |  |  |  |  |  |
| Net sales | $10815 | $10390 | $10475 | $8842 | $8230 |
| Airbags, Steering Wheels and Other<sup>1)</sup> | 7302 | 7023 | 7055 | 5807 | 5380 |
| Seatbelt Products and Other<sup>1)</sup> | 3513 | 3367 | 3420 | 3035 | 2850 |
| Operating income | 1088 | 979 | 690 | 659 | 675 |
| Net income attributable to controlling interest | 735 | 646 | 488 | 423 | 435 |
| Earnings per share – basic<sup>2)</sup> | 9.59 | 8.06 | 5.74 | 4.86 | 4.97 |
| Earnings per share – diluted<sup>2)</sup> | 9.55 | 8.04 | 5.72 | 4.85 | 4.96 |
| Gross margin<sup>3)</sup> | 19.2% | 18.5% | 17.4% | 15.8% | 18.4% |
| S,G&A in relation to sales | (5.3)% | (5.1)% | (4.8)% | (4.9)% | (5.3)% |
| R,D&E net in relation to sales | (3.8)% | (3.8)% | (4.1)% | (4.4)% | (4.7)% |
| Operating margin<sup>4)</sup> | 10.1% | 9.4% | 6.6% | 7.5% | 8.2% |
| Adjusted operating margin<sup>5,6)</sup> | 10.3% | 9.7% | 8.8% | 6.8% | 8.3% |
| **Balance Sheet** | **Balance Sheet** | **Balance Sheet** | **Balance Sheet** | **Balance Sheet** | **Balance Sheet** |
| Trade working capital<sup>6,7)</sup> | 1221 | 1115 | 1232 | 1183 | 1332 |
| Trade working capital in relation to sales<sup>8)</sup> | 10.8% | 10.7% | 11.2% | 12.7% | 15.7% |
| Receivables outstanding in relation to sales<sup>9)</sup> | 19.8% | 19.0% | 20.0% | 20.4% | 20.0% |
| Inventory outstanding in relation to sales<sup>10)</sup> | 8.8% | 8.8% | 9.2% | 10.4% | 9.2% |
| Payables outstanding in relation to sales<sup>11)</sup> | 17.8% | 17.2% | 18.0% | 18.1% | 13.5% |
| Total equity | 2582 | 2285 | 2570 | 2626 | 2648 |
| Total parent shareholders' equity per share | 34.43 | 29.26 | 30.93 | 30.30 | 30.10 |
| Current assets excluding cash | 3497 | 3153 | 3475 | 3119 | 2705 |
| Property, plant and equipment, net | 2419 | 2239 | 2192 | 1960 | 1855 |
| Goodwill and Intangible assets | 1386 | 1375 | 1385 | 1382 | 1395 |
| Capital employed | 4148 | 3840 | 3937 | 3810 | 3700 |
| Net debt<sup>6)</sup> | 1566 | 1554 | 1367 | 1184 | 1052 |
| Total assets | 8644 | 7804 | 8332 | 7717 | 7537 |
| Long-term debt | 1734 | 1522 | 1324 | 1054 | 1662 |
| Return on capital employed<sup>12)</sup> | 26.4% | 25.0% | 17.7% | 17.5% | 18.3% |
| Return on total equity<sup>13)</sup> | 30.0% | 27.2% | 19.0% | 16.3% | 17.1% |
| Total equity ratio | 30% | 29% | 31% | 34% | 35% |
| **Cash flow and other data** | **Cash flow and other data** | **Cash flow and other data** | **Cash flow and other data** | **Cash flow and other data** | **Cash flow and other data** |
| Operating cash flow | 1157 | 1059 | 982 | 713 | 754 |
| Depreciation and amortization | 407 | 387 | 378 | 363 | 394 |
| Capital expenditures, net | 423 | 563 | 569 | 485 | 454 |
| Capital expenditures, net in relation to sales | 3.9% | 5.4% | 5.4% | 5.5% | 5.5% |
| Free operating cash flow<sup>6,14)</sup> | 734 | 497 | 414 | 228 | 300 |
| Cash conversion<sup>6,15)</sup> | 100% | 77% | 85% | 54% | 69% |
| Direct shareholder return<sup>16)</sup> | 590 | 771 | 577 | 339 | 165 |
| Cash dividends paid per share | 3.12 | 2.74 | 2.66 | 2.58 | 1.88 |
| Number of shares outstanding (millions)<sup>17)</sup> | 74.7 | 77.7 | 82.6 | 86.2 | 87.5 |
| Number of employees, December 31 | 58000 | 59500 | 62900 | 61700 | 55900 |
| <sup>1)</sup> Including Corporate sales <sup>2)</sup> Net of treasury shares. <sup>3)</sup> Gross profit relative to sales. <sup>4)</sup> Operating income relative to sales. <sup>5)</sup> Excluding effects from capacity alignments, antitrust related matters and for FY 2023 the Andrews litigation settlement. <sup>6)</sup> Non-GAAP measure, for reconciliation see tables above. <sup>7)</sup> Outstanding receivables and outstanding inventory less outstanding payables. <sup>8)</sup> Outstanding receivables and outstanding inventory less outstanding payables relative to annualized fourth quarter sales. <sup>9)</sup> Outstanding receivables relative to annualized fourth quarter sales. <sup>10)</sup>Outstanding inventory relative to annualized fourth quarter sales. <sup>11)</sup> Outstanding payables relative to annualized fourth quarter sales. <sup>12)</sup> Operating income and income from equity method investments, relative to average capital employed. <sup>13)</sup> Income relative to total equity. <sup>14)</sup> Operating cash flow less Capital expenditures, net. <sup>15)</sup> Free operating cash flow relative to Net income. <sup>16)</sup> Dividends paid and Shares repurchased.<br><sup>17)</sup> At year end, excluding dilution and net of treasury shares. | <sup>1)</sup> Including Corporate sales <sup>2)</sup> Net of treasury shares. <sup>3)</sup> Gross profit relative to sales. <sup>4)</sup> Operating income relative to sales. <sup>5)</sup> Excluding effects from capacity alignments, antitrust related matters and for FY 2023 the Andrews litigation settlement. <sup>6)</sup> Non-GAAP measure, for reconciliation see tables above. <sup>7)</sup> Outstanding receivables and outstanding inventory less outstanding payables. <sup>8)</sup> Outstanding receivables and outstanding inventory less outstanding payables relative to annualized fourth quarter sales. <sup>9)</sup> Outstanding receivables relative to annualized fourth quarter sales. <sup>10)</sup>Outstanding inventory relative to annualized fourth quarter sales. <sup>11)</sup> Outstanding payables relative to annualized fourth quarter sales. <sup>12)</sup> Operating income and income from equity method investments, relative to average capital employed. <sup>13)</sup> Income relative to total equity. <sup>14)</sup> Operating cash flow less Capital expenditures, net. <sup>15)</sup> Free operating cash flow relative to Net income. <sup>16)</sup> Dividends paid and Shares repurchased.<br><sup>17)</sup> At year end, excluding dilution and net of treasury shares. | <sup>1)</sup> Including Corporate sales <sup>2)</sup> Net of treasury shares. <sup>3)</sup> Gross profit relative to sales. <sup>4)</sup> Operating income relative to sales. <sup>5)</sup> Excluding effects from capacity alignments, antitrust related matters and for FY 2023 the Andrews litigation settlement. <sup>6)</sup> Non-GAAP measure, for reconciliation see tables above. <sup>7)</sup> Outstanding receivables and outstanding inventory less outstanding payables. <sup>8)</sup> Outstanding receivables and outstanding inventory less outstanding payables relative to annualized fourth quarter sales. <sup>9)</sup> Outstanding receivables relative to annualized fourth quarter sales. <sup>10)</sup>Outstanding inventory relative to annualized fourth quarter sales. <sup>11)</sup> Outstanding payables relative to annualized fourth quarter sales. <sup>12)</sup> Operating income and income from equity method investments, relative to average capital employed. <sup>13)</sup> Income relative to total equity. <sup>14)</sup> Operating cash flow less Capital expenditures, net. <sup>15)</sup> Free operating cash flow relative to Net income. <sup>16)</sup> Dividends paid and Shares repurchased.<br><sup>17)</sup> At year end, excluding dilution and net of treasury shares. | <sup>1)</sup> Including Corporate sales <sup>2)</sup> Net of treasury shares. <sup>3)</sup> Gross profit relative to sales. <sup>4)</sup> Operating income relative to sales. <sup>5)</sup> Excluding effects from capacity alignments, antitrust related matters and for FY 2023 the Andrews litigation settlement. <sup>6)</sup> Non-GAAP measure, for reconciliation see tables above. <sup>7)</sup> Outstanding receivables and outstanding inventory less outstanding payables. <sup>8)</sup> Outstanding receivables and outstanding inventory less outstanding payables relative to annualized fourth quarter sales. <sup>9)</sup> Outstanding receivables relative to annualized fourth quarter sales. <sup>10)</sup>Outstanding inventory relative to annualized fourth quarter sales. <sup>11)</sup> Outstanding payables relative to annualized fourth quarter sales. <sup>12)</sup> Operating income and income from equity method investments, relative to average capital employed. <sup>13)</sup> Income relative to total equity. <sup>14)</sup> Operating cash flow less Capital expenditures, net. <sup>15)</sup> Free operating cash flow relative to Net income. <sup>16)</sup> Dividends paid and Shares repurchased.<br><sup>17)</sup> At year end, excluding dilution and net of treasury shares. | <sup>1)</sup> Including Corporate sales <sup>2)</sup> Net of treasury shares. <sup>3)</sup> Gross profit relative to sales. <sup>4)</sup> Operating income relative to sales. <sup>5)</sup> Excluding effects from capacity alignments, antitrust related matters and for FY 2023 the Andrews litigation settlement. <sup>6)</sup> Non-GAAP measure, for reconciliation see tables above. <sup>7)</sup> Outstanding receivables and outstanding inventory less outstanding payables. <sup>8)</sup> Outstanding receivables and outstanding inventory less outstanding payables relative to annualized fourth quarter sales. <sup>9)</sup> Outstanding receivables relative to annualized fourth quarter sales. <sup>10)</sup>Outstanding inventory relative to annualized fourth quarter sales. <sup>11)</sup> Outstanding payables relative to annualized fourth quarter sales. <sup>12)</sup> Operating income and income from equity method investments, relative to average capital employed. <sup>13)</sup> Income relative to total equity. <sup>14)</sup> Operating cash flow less Capital expenditures, net. <sup>15)</sup> Free operating cash flow relative to Net income. <sup>16)</sup> Dividends paid and Shares repurchased.<br><sup>17)</sup> At year end, excluding dilution and net of treasury shares. | <sup>1)</sup> Including Corporate sales <sup>2)</sup> Net of treasury shares. <sup>3)</sup> Gross profit relative to sales. <sup>4)</sup> Operating income relative to sales. <sup>5)</sup> Excluding effects from capacity alignments, antitrust related matters and for FY 2023 the Andrews litigation settlement. <sup>6)</sup> Non-GAAP measure, for reconciliation see tables above. <sup>7)</sup> Outstanding receivables and outstanding inventory less outstanding payables. <sup>8)</sup> Outstanding receivables and outstanding inventory less outstanding payables relative to annualized fourth quarter sales. <sup>9)</sup> Outstanding receivables relative to annualized fourth quarter sales. <sup>10)</sup>Outstanding inventory relative to annualized fourth quarter sales. <sup>11)</sup> Outstanding payables relative to annualized fourth quarter sales. <sup>12)</sup> Operating income and income from equity method investments, relative to average capital employed. <sup>13)</sup> Income relative to total equity. <sup>14)</sup> Operating cash flow less Capital expenditures, net. <sup>15)</sup> Free operating cash flow relative to Net income. <sup>16)</sup> Dividends paid and Shares repurchased.<br><sup>17)</sup> At year end, excluding dilution and net of treasury shares. |

---

------